Clincosm LogoSign in Get a demo

graves ophthalmopathy

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Graves Ophthalmopathy Trial in Sofia (Methylprednisolone)

Completed
  • Graves Ophthalmopathy
  • Sofia, Bulgaria
    University Hospital of Endocrinology
Mar 29, 2023

Graves Ophthalmopathy Trial in Sofia (Orbital radiotherapy)

Completed
  • Graves Ophthalmopathy
  • Orbital radiotherapy
  • Sofia, Bulgaria
    University Hospital of Endocrinology
Mar 7, 2023

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Beverly Hills, California
  • +22 more
Jan 30, 2023

Associated With Mental Fatigue in Graves' Disease

Recruiting
  • Graves Disease
  • +4 more
    • Gothenburg, Sweden
      Department of Endocrinology, Sahlgrenska University Hospital
    Jan 4, 2023

    Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)

    Recruiting
    • Graves Ophthalmopathy
    • Hsinchu, Taiwan
    • +1 more
    Dec 1, 2022

    Graves Ophthalmopathy Trial in Pisa (Sirolimus)

    Not yet recruiting
    • Graves Ophthalmopathy
    • Pisa, Italy
      Ospedale Cisanello-Endocrinology II
    Nov 2, 2022

    Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)

    Recruiting
    • Graves Ophthalmopathy
    • Tocilizumab 20 Mg/mL Intravenous Solution
    • MethylPREDNISolone Injectable Solution
    • Milano, MI, Italy
    • +3 more
    Aug 3, 2022

    Sirolimus in Graves' Orbitopathy

    Completed
    • Graves Ophthalmopathy
    • Pisa, PI, Italy
      Endocrinologia II
    Apr 19, 2022

    Glucocorticoids and Bone in Graves' Ophthalmopathy

    Active, not recruiting
    • Graves Ophthalmopathy
    • Aarhus C, Central Denmark Region, Denmark
    • +1 more
    Feb 21, 2022

    Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy Trial in Malmö (Simvastatin 40mg)

    Recruiting
    • Graves Ophthalmopathy
    • +2 more
    • Simvastatin 40mg
    • Malmö, Sweden
      Dpt. of Endocrinology, SUS Malmö
    Nov 17, 2021

    Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)

    Recruiting
    • Graves Ophthalmopathy
    • +8 more
    • Doxycycline hyclate
    • Placebo
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Nov 16, 2021

    Strabismus, Mechanical, Graves Ophthalmopathy Trial (supramaximal rectus recession, normal rectus recession)

    Not yet recruiting
    • Strabismus, Mechanical
    • Graves Ophthalmopathy
    • supramaximal rectus recession
    • normal rectus recession
    • (no location specified)
    Jun 15, 2021

    Exophthalmos, Graves Ophthalmopathy, Orbital Tumor Trial in Zurich (Exophthalmos measurement)

    Recruiting
    • Exophthalmos
    • +3 more
    • Exophthalmos measurement
    • Zurich, Switzerland
      Ophthalmology Department, University Hospital Zurich
    Jan 10, 2021

    Graves Ophthalmopathy Trial in Newcastle upon Tyne (Otelixizumab - low dose, Otelixizumab - medium low dose, Otelixizumab -

    Terminated
    Has Results
    • Graves Ophthalmopathy
    • Otelixizumab - low dose
    • +5 more
    • Newcastle upon Tyne, United Kingdom
      GSK Investigational Site
    Oct 8, 2020

    Genetics and Epigenetics of Graves' Orbitopathy

    Completed
    • Graves Ophthalmopathy
    • No Intervention
    • Pisa, Italy
      Ospedale Cisanello-Endocrinology I and II
    Jul 22, 2020

    Heart Rhythm After Intravenous Methylprednisolone Administration

    Completed
    • Graves Disease
    • +5 more
    • Intravenous Methylprednisolone
    • (no location specified)
    May 13, 2020

    Graves Ophthalmopathy Trial in São Paulo (Orbital decompression)

    Completed
    • Graves Ophthalmopathy
    • Orbital decompression
    • São Paulo, Brazil
      University of Sao Paulo General Hospital
    Aug 11, 2019

    Graves Disease, Graves Ophthalmopathy, Liver Diseases Trial (every week IVMP therapy, very high doses IVMP therapy)

    Completed
    • Graves Disease
    • +13 more
    • every week IVMP therapy
    • very high doses IVMP therapy
    • (no location specified)
    Sep 11, 2018

    Anti-insulin-like Growth Factor-1 Receptor Antibodies in Graves'

    Completed
    • Graves Ophthalmopathy
    • +2 more
    • Serum antibodies against the IGF-1R
    • Pisa, Italy
      Endocrinology Unit I, University of Pisa
    Jul 26, 2018

    Blood Pressure

    Completed
    • Graves Disease
    • +4 more
    • (no location specified)
    Jul 17, 2018

    Coagulation After Intravenous Methylprednisolone Administration

    Completed
    • Graves' Disease
    • +3 more
    • (no location specified)
    May 12, 2018

    T and B Cells in Graves' Orbitopathy

    Completed
    • Graves Ophthalmopathy
    • No intervention
    • (no location specified)
    Feb 9, 2018

    Fibroblast Growth Factor and Fibroblast in Thyroid Eye Disease

    Unknown status
    • Graves Ophthalmopathy
      • Taipei, Taiwan
        National Taiwan University Hospital Taipei, Taiwan
      Oct 29, 2017

      Graves Ophthalmopathy Trial (Azithromycin)

      Withdrawn
      • Graves Ophthalmopathy
      • (no location specified)
      Apr 25, 2017